Neuroendocrine cells are unique in their ability to act both as nerve cells and hormone-making cells. They're scattered ...
Researchers at Michigan Medicine report a potential new therapeutic target for gastrointestinal neuroendocrine tumors: a ...
Regulatory review timelines shifted from March 29 to June 29, 2026, after FDA requested more time to assess CMC/manufacturing ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
BOSTON, March 26, 2026 (GLOBE NEWSWIRE)-- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ...
University of Michigan researchers have identified a new target that can suppress tumor growth. Their findings may lead to new treatment methods for gastroenteropancreatic neuroendocrine tumors.